Lv1
50 积分 2024-11-07 加入
Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement
1个月前
已完结
Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
1个月前
已完结
Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes
1个月前
已完结
LSD1 in drug discovery: From biological function to clinical application
1个月前
已完结
Recent advances of LSD1/KDM1A inhibitors for disease therapy
1个月前
已完结
Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia
2个月前
已完结
Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapies
2个月前
已完结
Menin inhibitors in KMT2A-rearranged and NPM1-mutated acute leukemia: A scoping review of safety and efficacy
2个月前
已完结
Combination Strategies with Menin Inhibitors for Acute Leukemia
2个月前
已完结
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
2个月前
已完结
皖公网安备34019202002308
